✨ Trustee Appointment and Medicine Notices




18 JULY 2013 NEW ZEALAND GAZETTE, No. 91 2465

I am now pleased to appoint
Rakihia (Rick) Tahumata Tau
as a trustee of the Trust.

I consequently officially remove
Guy Richard Kiniwe Royal
from his position as a trustee of the Trust (published in the New Zealand Gazette, 21 April 2011, No. 55, page 1276).

Dated at Wellington this 23rd day of June 2013.

HON TIM GROSER, Minister for Climate Change Issues.

go4449

Health

Medicines Act 1981

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Glycopyrronium Bromide 0.5mg/mL and Neostigmine Metilsulfate 2.5mg/mL Injection

Active Ingredients:

  • Glycopyrronium bromide 0.5mg/mL
  • Neostigmine metilsulfate 2.5mg/mL

Dosage Form: Solution for injection

New Zealand Sponsor: Max Health Limited

Manufacturer: Martindale Pharmaceuticals, Essex, United Kingdom

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 11th day of July 2013.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go4469

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: AS-Pemetrexed

Active Ingredient: Pemetrexed disodium hemipentahydrate 604.12mg equivalent to pemetrexed 500mg

Dosage Form: Powder for infusion

New Zealand Sponsor: Agila (NZ) Pty Limited

Manufacturer: Onco Therapies Limited, Bangalore Karnataka, India

Product: GN-Pemetrexed

Active Ingredient: Pemetrexed disodium hemipentahydrate 604.12mg equivalent to pemetrexed 500mg

Dosage Form: Powder for infusion

New Zealand Sponsor: Agila (NZ) Pty Limited

Manufacturer: Onco Therapies Limited, Bangalore Karnataka, India

Product: Mylan-Bosentan

Active Ingredient: Bosentan monohydrate 64.541mg equivalent to bosentan anhydrous 62.5mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Mylan New Zealand Limited

Manufacturer: Mylan Laboratories Limited, Maharashtra State, India

Product: Mylan-Bosentan

Active Ingredient: Bosentan monohydrate 129.082mg equivalent to bosentan anhydrous 125mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Mylan New Zealand Limited

Manufacturer: Mylan Laboratories Limited, Maharashtra State, India



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2013, No 91





✨ LLM interpretation of page content

πŸ›οΈ Appointment and Removal of Trustee

πŸ›οΈ Governance & Central Administration
23 June 2013
Trustee, Appointment, Removal, Climate Change Issues
  • Rakihia (Rick) Tahumata Tau, Appointed as trustee
  • Guy Richard Kiniwe Royal, Removed as trustee

  • HON TIM GROSER, Minister for Climate Change Issues

πŸ₯ Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
11 July 2013
Medicine, Provisional Consent, Glycopyrronium Bromide, Neostigmine Metilsulfate
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicine, Consent, Pemetrexed, Bosentan